Ruud J.T. Smeenk

Range of antinuclear antibodies in “healthy” individuals

Eng M. Tan, T. E. W. Feltkamp, Josef S Smolen et al. · Arthritis & Rheumatism · 1997 · 858 citations

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

P. Charles, Ruud J.T. Smeenk, Jan de Jong et al. · Arthritis & Rheumatism · 2000 · 530 citations

A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities: I. Precision, sensitivity, and specificity

Eng M. Tan, Josef S Smolen, J. Steven McDougal et al. · Arthritis & Rheumatism · 1999 · 169 citations

Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively.

A. J. G. Swaak, Johannes C. Nossent, W Bronsveld et al. · Annals of the Rheumatic Diseases · 1989 · 133 citations · Full text

Characterization of the autoantigen calreticulin

Luis A. Rokeach, Jeanne A. Haselby, Jan F. Meilof et al. · The Journal of Immunology · 1991 · 130 citations · Full text